Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

June 20, 2014

Biotechnology Venture Capital Surge Could Help Aching Pipelines

Noticeable product improvements may be on the way thanks to the deep pockets of VC firms.

Biotechnology Venture Capital Surge Could Help Aching Pipelines

According to the MoneyTree Report, biotechnology was the second largest investment area for venture capitalists. [© Bobby4237 - Fotolia.com]

Top pharmaceuticals face a dilemma in that many blockbuster drugs are losing patent protection and existing pipelines may not compensate for lost revenues The choice for many is layoffs, office closings, downsizing or to innovate with new products Most companies will do the former if they must but prefer the ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content